Financial Results

Key highlights

Filter

Period

Filter by

recent search

Reset

Showing: 1 – 05 of 23 Financial Results

Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
 –  28 July 2022

28 July 2022

Download
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance

Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:


Ipsen delivers a strong sales performance in the first quarter of 2022
 –  27 April 2022

27 April 2022

Download
Ipsen delivers a strong sales performance in the first quarter of 2022

Attachment


Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business
 –  11 February 2022

11 February 2022

Download
Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business

Attachment


Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance
 –  21 October 2021

21 October 2021

Download
Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance


Ipsen delivers strong H1 2021 results and upgrades full-year guidance
 –  26 July 2021

26 July 2021

Download
Ipsen delivers strong H1 2021 results and upgrades full-year guidance


1 2 3 4 5

Your dedicated contacts